- Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome2021 | Second Faculty of Medicine
- Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower-risk myelodysplastic neoplasms2024 | First Faculty of Medicine, Faculty of Science, Faculty of Physical Education and Sport
- Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial2023 | First Faculty of Medicine
- Moderate alcohol intake and lower risk of atherosclerosis, myocardial infarction and brain event2004 | Central Library of Charles University
- Safety profile of lenalidomide in patients with lower-risk myelodysplastic syndromes without del(5q): results of a phase 3 trial2018 | First Faculty of Medicine
- High level of full-length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide2015 | Faculty of Science
- TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes2016 | First Faculty of Medicine
- Aging-Related Gene Expression Signatures Define Likelihood of Disease Progression in Patients with Lower-Risk Myelodysplastic SyndromesPublication without faculty affiliation
- RUNX1 mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS2022 | First Faculty of Medicine, Faculty of Science
- Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes2021 | First Faculty of Medicine
- Hematopoietic stem cells of lower-risk MDS patients with rapid progression show quiescent-like cell state similar to that of higher-risk MDS cellsPublication without faculty affiliation
- Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin +/- prednisone addition to lenalidomide in refractory or relapsed patients)2018 | First Faculty of Medicine
- Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents2016 | First Faculty of Medicine
- Treatment of dyslipidemia as a prevention of diabetes complications2009 | First Faculty of Medicine
- Does cord blood transplantation have a future? The immunological perspective2000 | Central Library of Charles University
- Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Statins in the patients with acute coronary syndromes2011 | First Faculty of Medicine
- Vegetariarianism and health2021 | First Faculty of Medicine
- Comparison of percutaneous and open approach to radiofrequency ablation of colorectal liver metastases in Teaching Hospital Pilsen in 2001-20152016 | Faculty of Medicine in Pilsen
- The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial2016 | Publication without faculty affiliation
- Iron in pregnancy2016 | First Faculty of Medicine
- Research Report University Hospital clinical trial AZA-MDS-003Publication without faculty affiliation
- Photosensitivity in children2014 | Third Faculty of Medicine
- Treatment of Atrial Fibrillation in Patients with Dementia: A Cohort Study from the Swedish Dementia Registry2018 | Central Library of Charles University
- Laparoscopic reconstructions of duplex kidney anomalies in children - 33 consecutive proceduresPublication without faculty affiliation
- What the patient can't do, insulin can do?2020 | Third Faculty of Medicine
- Apixaban2014 | First Faculty of Medicine
- Prevention of cardiovascular disease in childhood2012 | Publication without faculty affiliation
- The importance of physical activity in cancer patients and its influence on the prevention of cancer2021 | Faculty of Medicine in Pilsen
- Antidiabetic drugs of interest2016 | Second Faculty of Medicine
